Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Page 1
How I treat refractory CRS and ICANS after CAR T-cell therapy.
Blood. 2023 May 18;141(20):2430-2442. doi: 10.1182/blood.2022017414.
Blood. 2023.
PMID: 36989488
Free article.
STAT5 activation promotes progression and chemotherapy-resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS, Saw J, Boyle JA, Haigh K, Litalien V, McCalmont HR, Evans K, Lock RB, Jane SM, Haigh JJ, Curtis DJ.
Tremblay CS, et al.
Blood. 2023 Mar 29:blood.2022016322. doi: 10.1182/blood.2022016322. Online ahead of print.
Blood. 2023.
PMID: 36989489
Item in Clipboard
CHROMATIN ACTIVATION PROFILING OF STEREOTYPED CHRONIC LYMPHOCYTIC LEUKEMIAS REVEALS A SUBSET #8 SPECIFIC SIGNATURE.
Tsagiopoulou M, Chapaprieta V, Russiñol N, García-Torre B, Pechlivanis N, Nadeu F, Papakonstantinou N, Stavroyianni N, Chatzidimitriou A, Psomopoulos F, Campo E, Stamatopoulos K, Martin-Subero JI.
Tsagiopoulou M, et al.
Blood. 2023 Mar 29:blood.2022016587. doi: 10.1182/blood.2022016587. Online ahead of print.
Blood. 2023.
PMID: 36989492
Item in Clipboard
Cite
Cite